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Abstract: In addition to oxidative and antibiotic
mechanisms of antimicrobial activity, macro-
phages are able to deprive intracellular pathogens
of required nutrients. Thus, microbial killing may
not rely only in the toxic environment the microbe
reaches but also may result from the scarcity of
nutrients in the cellular compartment it occupies.
Here, we analyze evidence for such nutriprive
(from the latin privare, to deprive of nutrients),
antimicrobial mechanisms. Although the direct
analysis of nutrient availability is most often not
feasible, indirect evidence of lack of nutrients in
the microbial organelles has been inferred from
the study of mutants, the analysis of gene expres-
sion, and the consequences of changing the intra-
cellular location of the pathogen. We propose that
according to the microbe and its survival strategy,
different mechanisms to impede access to nutrients
may be constitutively present or may be induced by
cytokines and other pathways. Thus, membrane
transporters may remove nutrients from vacuolar
compartments, and enzymes may degrade some
growth factors. A series of diverse compounds may
sequester other molecules required for microbial
growth, as exemplified by the action of iron chela-
tors. Modulation of vesicular trafficking may pre-
vent the fusion of certain vesicles containing nutri-
ents with those containing the pathogen, counter-
acting the evasion strategies of the pathogen. The
understanding of these mechanisms will certainly
help in designing new therapeutic and prophylactic
approaches to preventing infectious diseases. J.
Leukoc. Biol. 79: 1117–1128; 2006.
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INTRODUCTION
The research into the mechanisms used by professional phago-
cytes to control microbial growth has been centered on the
identification of toxic molecules or “toxic environments” that
lead to their demise. This was started with the discovery of the
phagocytes’ oxidative burst and the study of the role of oxygen
radicals in the 1960s [1]. Soon after, oxygen-independent
mechanisms were suspected [1], and in the 1980s, nitric oxide
(NO) production by a phagocyte synthase was identified as a
major pathway of microbial elimination [2]. Even today, NO
and its derivatives are considered the major players in the
killing of intracellular parasites. However, numerous reports
highlighted the existence of antimicrobial activity, which is not
dependent on NO generation. NO-independent mechanisms of
control of Listeria monocytogenes [3], Legionella pneumophila
[4, 5], Mycobacterium avium [6, 7], Trypanosoma cruzi [8], and
Anaplasma phagocytophilum [9] have been reported in the
literature. Even when NO has been shown to play an important
role in the control of microbial proliferation such as in the case
of Mycobacterium tuberculosis, NO production by itself does not
explain the ability of a host to control this pathogen [10]. Using
double-knock mice, deficient in the generation of oxygen or
nitrogen-reactive species, Shiloh et al. [11] concluded for the
existence of additional antimicrobial mechanisms active
against salmonellae and listeriae.
The lifestyles of intracellular pathogens vary considerably.
Some appear to block vacuole maturation, arresting it at a
certain stage (e.g., mycobacteria), some allow full maturation
(e.g., Coxiella and certain Leishmania), and others appear to
“construct” their own replicative organelle (e.g., Legionella,
Brucella, and Salmonella). Mycobacteria and Salmonellae pre-
vent the fusion of the pathogen-containing vacuole with the
lysosome. Whereas the former remain in a compartment with
early/late endosomal characteristics and continuously interact
with endosomes [12–14], the latter only transiently inhabit
such a compartment (containing Rab5 and early endosomal
antigen 1), moving onto a more modified, microtubule-asssoci-
ated vesicular system, the Salmonella-induced filaments,
which acidify through the action of vacuolar adenosinetriphos-
phatases (ATPases) and contain Rab7, its effector Rab-inter-
acting lysosomal protein, and lysosomal-associated membrane
protein-1 (LAMP-1) [15]. In contrast, parasitophorous vacuoles
containing certain species of Leishmania mature into lysosom-
al-like compartments rich in cathepsins and contain Rab7,
vacuolar ATPases, LAMP-1 and -2, and the mannose-6-phos-
phate receptor [16, 17]. These parasitophorous vacuoles are
extremely fusogenic, acquiring material obtained by fluid-
phase endocytosis [16, 18], from autophagic vacuoles [17], and
even large structures such as phagocytosed zymosan [19, 20].
In contrast, the L. pneumophila phagosome has been shown to
interact with the endoplasmic reticulum (ER) [21], but as
replication of the bacteria occurs, replication vacuoles become
acidic and begin interacting with the lysosomal compartment
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[22]. Clearly distinct is the vacuole occupied by Toxoplasma
gondii: It does not interact with endosomes or lysosomes, does
not express the vacuolar ATPases, and has unclear associa-
tions with the ER and mitochondria, likely mediated by the
parasite rhoptry protein (ROP) 2 [23, 24]. The Brucella vacu-
ole, conversely, avoids fusion with the lysosome and interacts
with, or at least acquires markers from, the ER [25, 26],
whereas the Chlamydia replication compartment, named in-
clusion, does not fuse with lysosomes and resides close to the
Golgi apparatus and mitochondria [23]. Some pathogens use a
more dramatic approach of lysing the vacuole membrane and
invading the cytoplasm. Examples of the latter include L.
monocytogenes [27], T. cruzi [28], and Shigellae [29].
Much of the information regarding how a microbe accesses
nutrients inside the macrophage is still lacking: What are those
nutrients? How are they obtained inside the host cell? Do the
subversion tactics used by intracellular microbes, namely
those that affect the normal trafficking of an ingested particle,
play a role in the acquisition of nutrients? Conversely, the
antimicrobial machinery of the phagocytes leading to restricted
access to nutrients (nutriprive mechanisms) is still unclear:
Does the macrophage limit access to nutrients at all? What are
the mechanisms involved? Are they constitutive, or can they be
induced upon activation by the immune system? Does the
macrophage play an active role in sabotaging the subversion
strategies of the ingested microbe, namely after activation?
Here, we will analyze some of these questions. We will
define nutrient in a relatively broad sense—any molecule
acting as a source of energy and reducing power as a source of
basic elements (carbon, sulfur, nitrogen, iron, and others) or as
a required growth factor, such as any organic molecule the
microbe is unable to synthesize, namely vitamins, amino acids,
or nucleotide bases. Electron acceptor molecules (in most
instances, oxygen) and physicochemical properties such as the
pH will also affect microbial growth and may be manipulated
by the phagocyte or the structures they form in vivo (e.g., the
granulomas). As we need to understand which nutrients are
accessed by proliferating intracellular pathogens to evaluate
whether they are limiting in a situation of restricted microbial
growth, the first part of this article will review what is known
about the nutritive potential of the macrophage habitat.
IDENTIFICATION OF THE NUTRITIVE
REQUIREMENTS OF INTRACELLULAR
PATHOGENS AND OF THE SMORGASBORD
SUPPLIED BY THE MACROPHAGE: EVIDENCE
FOR THE DEPRIVATION OF SPECIFIC
NUTRIENTS
Assessing the presence of specific nutrients in a defined com-
partment of a cell inhabited by a particular microbe is a
daunting task, which is yet to be performed for most candidate
molecules. This is made more complicated by the fact that
different intracellular parasites reside in different compart-
ments of the cell, many of which they custom-tailor themselves.
It is clear today that this subversion of the vacuolar trafficking
by many microbes is accomplished, not only to avoid the final
lysosomal destiny and thus the escape from a toxic and possi-
bly deadly environment but also to provide access to nutrients
required for the intracellular replication [30]. Some nutrients,
such as iron, can be more easily studied, and for those, there
is already a large body of information available. Other mole-
cules are much more difficult to study, and for those, we may
have to rely on indirect evidence. The following will review
evidence, direct or indirect, of access to nutrients by intramac-
rophage pathogens.
Direct analysis
Wagner et al. [31] used the hard X-ray microprobes to detect
X-ray fluorescence and to directly estimate the presence of 10
elements inside phagosomes containing mycobacteria. They
paid particular attention to iron and showed an enrichment in
vacuoles with time as well as a decrease following activation
with interferon- (IFN-) or tumor necrosis factor (TNF). Fur-
thermore, they showed that a mutant deficient in the synthesis
of the siderophore, mycobactin, was defective in its ability to
accumulate iron, showing that iron was supplied to the myco-
bacterial phagosome as it was used by the microbe, as ex-
pected. The study of iron is also amenable to analysis by
ultrastructural autoradiography [31] or by scintillation counting
on isolated bacterial cells [32] following the addition of 59Fe to
infected cells. The presence of a labile iron pool was also
detected in the cytoplasm using an iron-sensitive fluorescent
probe, calcein [33]. The pH in vesicular compartments can be
determined by the accumulation of certain weak bases upon
protonation in the low pH compartments followed by immuno-
chemical or fluorescence detection of the amount of probe
concentrated in such cellular compartments. This technique
was used to determine the lack of acidification in mycobac-
terial vacuoles [34]. The pH can also be assessed in vacu-
oles by using fluorescent probes with a pH-sensitive emis-
sion spectrum coupled to the microbial cells, and in this
way, reduced acidification of mycobacterial phagosomes has
been confirmed [35].
Indirect indications of the presence of nutrients
One indirect way to look at the availability of nutrients is to
study gene expression signatures. Another is to analyze the
natural requirement for growth factors (natural auxotrophy) or
to compare the growth of auxotrophic mutants with the growth
of wild-type microorganisms.
Study of auxotrophy
Salmonella does not assimilate folate. Instead, it synthesizes it
from para-amino-benzoic acid (PABA). As the host cannot
provide PABA, the microbe will not synthesize folate if the
synthesis of PABA is inhibited, hence the efficacy of sulfon-
amides in chemotherapy. In addition, Salmonella requires
2,3-dihydroxybenzoate (DHB) for enterochelin synthesis, and
again, this precursor cannot be provided by the host. Choris-
mate is a precursor for PABA and DHB. Hoiseth and Stocker
[36] produced a Salmonella mutant (aroA), which was unable
to synthesize chorismate. This model system is thus the ideal
situation to analyze how the lack of a nutrient (in this case, two,
none of which can be supplied by the host and thus represent
a situation of nutrient deprivation) will affect growth of a
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pathogen inside its host. These authors reported an increase in
50% lethal dose (LD50) from less than 20 bacteria for the
wild-type strain to more than 3  105 bacteria for the aro–
strain. Therefore, we can postulate that limitation of a nutrient
in a host would make an auxotroph for that nutrient to increase
its LD50 to such an extent and thus set the read-out for the
assessment of the presence of a specific nutrient or the exis-
tence of putative, nutriprive mechanisms in the host in the
context of salmonellosis. It should be kept in mind, however,
that other explanations may underlie an increase in LD50 of a
particular mutant and that even intracellular pathogens may at
some point be extracellular and thus have different nutrient
requirements. Table 1 summarizes the impact of auxotrophy
on the ability of intracellular pathogens to proliferate in vivo or
in cultured macrophages.
Fields et al. [37] screened 9516 Salmonella typhimurium
mutants for lack of survival in mouse macrophages and found
that the avirulent mutants included 12 auxotrophs (four purine,
four pyrimidine, one aromatic amino acid pathway, two histi-
dine, and one methionine auxotrophs). Most auxotrophs had
LD50 of 10
3 or greater. Leung and Finlay [38] produced a series
of mutants of S. typhimurium, which they analyzed for their
ability to proliferate inside the host. They found that purine,
uracil, and isoleucine/valine auxotrophs were unable to prolif-
erate in mice but survived in cultured macrophages. This
suggests that the intracellular niche occupied by Salmonella
does not provide the nutrients, which these auxotrophs require,
and furthermore, the lack of growth is likely not a result of
accrued susceptibility to the antimicrobial mechanisms of the
macrophage but rather the lack of nutrients. The fact that the
selection of the mutants was done on the basis of their inability
to grow after random mutagenesis also suggests that nutrients
other than purines, pyrimidines, and certain amino acids may
be accessible to the intravacuolar salmonellae. More careful
microbiological analysis shows that these mutants survive in
vivo in the infected organs for quite a long time (2–3 weeks
before the number slowly decreases over a 2-month period),
again making the point that the basic limitation to growth is the
lack of nutrients and not an increase in susceptibility to the
host’s toxic armamentarium [51]. In contrast, it has been shown
that only 3.2% of human clinical isolates of the typhoid bacil-
lus are prototrophic [39]. Indeed, most of the isolates were
auxotrophic for tryptophan, suggesting that at least this amino
acid is not limiting in the salmonella vacuole; otherwise, this
pathogen would not cause infection. The fact that glutamine
synthetase mutants of S. typhimurium were still virulent, and
only the simultaneous destruction of the genes encoding this
enzyme and that of the genes encoding the transporters of
glutamine could increase the LD50 to 10
5 bacteria [40]
suggests that glutamine may be available to salmonellae in
macrophages.
M. tuberculosis, albeit its slow replication rate, has no known
growth factor requirements [52]. Mycobacteria auxotrophs have
also been characterized, and the data are similar to those
obtained with Salmonella, inasmuch as a lack of purines and
certain amino acids appears to make the M. tuberculosis vac-
uole inhospitable to auxothophs, such as the purC [41, 42], the
leuD [43], and the lysA [44]. However, when proline and
tryptophan auxotrophs were compared [53], the latter appeared
to be less able to survive than the former, suggesting that the
deficiency in certain amino acids is more severe than others or
that the mutations may in some way affect the fitness of the
mycobacteria to survive in the macrophage. In the case of
mycobacteria, it is not clear whether the auxotrophy leads to an
increase in susceptibility to antimicrobial (e.g., oxidative)
mechanisms or to stress or if an inability to run salvage
pathways for the required nutrient does not compensate for its
presence in the vacuole. Similar caution must be used in
interpreting the low virulence of panthotenate auxotrophs [45].
Diminished amounts of panthotenic acid may lead to defects in
fatty acid metabolism and polyketide synthesis with possible
deficiencies at the level of resistance to oxidative damage and
reduced synthesis of virulence factors. When comparing the
growth characteristics of a leucine BCG auxotroph, Jacobs and
colleagues [46, 47] found that the lack of in vivo virulence
exhibited by the mutant was related to its inability to prolifer-
ate inside a macrophage cell line and thus, concluded that
leucine was not available to the mycobacteria inside the host
cell. It is thus safe to speculate that the concentration of amino
acids, purines, and vitamins is likely to be reduced severely in
the mycobacterial vacuole.
L. pneumophila is quite demanding in regards to its nutri-
tional requirements. However, it was shown that tryptophan
auxotrophs are still able to proliferate in human monocytes,
suggesting no limitation of this nutrient in the pathogen vacu-
ole [48]. In contrast, thymidine auxotrophs did not grow in
monocytes [48], supporting the notion that phagosomes lack
this nucleotide. Likewise, B. melitensis mutants, deficient in
purine biosynthesis, exhibit reduced virulence in mice [49]. An
extensive analysis of Brucella suis mutants unveiled 15 amino
TABLE 1. The Effect of Auxotrophy on the Ability of Pathogens
to Proliferate in vivo or in Cultured Macrophages
Pathogen Auxotrophy
Effect on
growth References
Salmonella spp. Purines Reduction 37, 38
Pyrimidines Reduction 37, 38
Aromatic amino
acids
Reduction 37
Histidine Reduction 37
Methionine Reduction 37
Isoleucine/valine Reduction 38
Tryptophan None 39
Glutamine None 40
M. tuberculosis Purines Reduction 41, 42
Leucine Reduction 43
Lysine Reduction 44
Panthotenate Reduction 45
Mycobacterium bovis
BCG
Leucine Reduction 46, 47
L. pneumophila Tryptophan None 48
Thymidine Reduction 48
Brucella melitensis Purines Reduction 49
L. monocytogenes Several amino
acids
None 50
Adenine None 50
Uracil None 50
Niacin None 50
BCG, Bacillus Calmette-Gue´rin.
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acid biosynthetic genes and five purine/pyrimidine biosyn-
thetic genes whose mutation would lead to attenuation of the
pathogen in cultured macrophages, suggesting that the Brucel-
la-containing vacuole is poor in such nutrients [54]. It should
be noted that the Legionella and the Brucella vacuoles possess
markers of the ER, and yet, only the latter appears to be
limiting in amino acids, showing that they are indeed distinct
compartments.
In contrast, the cytoplasm probably presents no such restric-
tions, and even naturally auxotrophic L. monocytogenes can
proliferate in this locale. In fact, this bacterium was shown to
be quite demanding in regards to its growth-factor require-
ments: Seven amino acids and the vitamins riboflavin, thia-
mine, biotin, and thioctic acid are required for in vitro growth,
and it is quite dependent on glucose (or some substituting
sugar) for proliferation [55]. If on top of this natural auxotrophy,
auxotrophic mutants are induced for additional amino acids,
adenine, uracil, or niacin, listeriae are still able to proliferate
intracellularly [50], suggesting no restriction of all these nu-
trients in the cytoplasm of macrophages. As already mentioned,
the cytoplasm also has iron available as a labile iron pool [33].
It is not surprising that when made unable to egress the
vacuole, L. monocytogenes loses its ability to replicate [56, 57],
probably as it no longer obtains the required nutrients.
Toxoplasma requires cholesterol [58, 59] and purines [60] to
proliferate. It is thus fair to suppose that the isolated vacuole it
inhabits has access to these two groups of molecules. Choles-
terol is obtained from low-density lipoproteins obtained
through receptor-mediated endocytosis and recycled through
the lysosomal compartment [58], whereas purines may reach
the parasitophorous vacuole (PV) from the cytosol through
functional pores in the PV membrane [61]. Similarly, T. cruzi,
a cytosol inhabitant, and Leishmania, an inhabitant of an
almost mature phagosome, also require purines [62] and must
obtain them from these locations. Whereas no restrictions are
apparent in a cytosolic location, the intravacuolar Leishmania
parasites should resort to some strategy to obtain such metab-
olites. It has been reported that these parasitophorous vacuoles
are extremely fusogenic and thus prone to obtain cargo from
many intracellular vesicular compartments [16, 18–20], as
they also contain an organic anion transporter, which pumps
small anions from the cytoplasm [17].
The data discussed above strongly suggest that intracellular
pathogens encounter macrophage niches, which can supply
selected nutrients, and as might be expected from the variety of
interactions these microbes establish with their host cell, this
supply of nutrients varies according to the pathogen under
study. These studies do not always allow us to tell whether
certain nutrients are available to the pathogen, as they sub-
verted the function of the phagocyte, or whether they are not
restricted at all, as they would also not be to nonpathogenic
microbes. Additional studies enlarge this picture as will be
discussed next.
Study of (other) metabolic mutants
Following the identification of the enzyme isocitrate lyase, an
enzyme involved in the anaplerotic pathway known as the
glyoxylate cycle, as a major protein produced during mycobac-
terial infection of macrophages [63], it was shown that this
enzyme is required for the virulence of M. tuberculosis [64].
Today, it has also been shown to be essential for the replication
of Salmonella [65] and fungi such as Candida albicans [66]
inside their hosts. The current interpretation of these mutants
states that the lack of a functional glyoxylate cycle impedes the
survival on a one- or two-carbon source and therefore, that the
vacuole inhabited by the microbes only has access to these
carbon sources, namely fatty acids. In the case of mycobacteria
and salmonellae, this was shown to occur late in infection in a
chronic phase where granulomas are expected to be fully
organized. It should be stressed, however, that other interpre-
tations are possible as well to explain the phenotype of the
isocitrate lyase mutants. This enzyme is induced in anaerobic
conditions and may participate in recycling reduced nicotin-
amide adenine dinucleotide (NADH) into NAD with produc-
tion of glycine from the reductive amination of glyoxylate by
glycine dehydrogenase [67].
Mutations affecting iron acquisition were shown to reduce
virulence of different intracellular pathogens: L. pneumophila
mutants with defective iron acquisition or assimilation were
impaired in their ability to proliferate in a macrophage cell line
[68], and mutations in M. tuberculosis leading to disruption of
the mycobactin synthesis [69] or to overexpression of an iron-
dependent repressor [70] reduced considerably the prolifera-
tive capacity of this microbe in vivo. Thus, although iron is
available inside vacuoles inhabited by intracellular pathogens,
it is likely present in suboptimal concentrations or must be
removed from host chelating molecules such that these patho-
gens rely on efficient iron acquisition systems for proliferation.
S. typhimurium mutants deficient in the MgtCB genes are
unable to proliferate in macrophages, a defect that can be
mimicked in axenic cultures by inoculating these mutants in
low Mg2 media [71]. Similarly, the analysis of M. tuberculosis
MgtC mutants has led to the suggestion that the vacuole
harboring this bacterium is mildly acidic and with limiting
levels of magnesium [72]. Recently, it was also shown that
MgtC is required for intra-macrophage growth of B. suis [73],
illustrating the possibility that Mg2 is in general limiting
inside macrophage vacuolar compartments.
The reduction in the ability to proliferate in mice of a narG
mutant of M. bovis BCG suggests that mycobacteria, residing in
granuloma macrophages, use nitrate respiration and therefore,
that oxygen is limiting in these cells [74].
The mutation of the gene encoding an amino acid transporter
PhtA in L. pneumophila has allowed the identification of thre-
onine as an essential nutrient acquired by this pathogen inside
macrophages [75]. Conversely, the blocking of the function or
the gene silencing of a neutral amino acid transporter SLC1A5
in macrophages was shown to severely reduce the proliferation
of L. pneumophila [76]. The expression of this transporter is
highly up-regulated upon infection of the host cell [76]. Thus,
it appears that this pathogen, relying on amino acids as growth-
supporting nutrients, recruits host cell machinery to satisfy its
nutritive requirements.
Expression profiling
Many genetic techniques have been designed to determine the
genes that are regulated upon phagocytosis, namely in vivo
expression technologies (IVET) and signature-tagged mutagen-
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esis (STM). For example, using an IVET approach, it was
shown that upon infection, S. typhimurium faces an environ-
ment poor in iron, magnesium, and copper [77]. However, with
ways to analyze the expression of hundreds of genes through
the use of high-throughput analysis technologies, namely mi-
croarrays, it is becoming possible to look for signatures in
expression related to particular growth conditions. One can, for
example, study the up- or down-regulation in expression of
many different genes in response to hypoxia, nutrient depriva-
tion, oxidative stress, and other cultural conditions and then
compare the changes observed with those that occur once the
microbe is ingested by macrophages in culture or even when
they infected the host. Several studies have thus defined a
series of regulons and compared them with the expression
profile induced in macrophages, cultured in vitro or from in
vivo experiments. One such study using Salmonella observed
changes in the expression of 919 genes (approximately one-
fifth of the genome-coding capacity), and changes suggested
that the Salmonella-containing vacuole in macrophages cul-
tured in vitro is poor in phosphate (given the strong up-
regulation of the phosphate-starvation loci) and magnesium
(there was an increase in expression of the genes mgtBC) and
is acidic (some of the genes involved in the acid-tolerance
response are indeed induced) [78]. Curiously, data in that
report suggest no limitation in amino acids (namely the aro-
matic ones), iron [although a macrophage with a defective
natural resistance-associated macrophage protein 1 (Nramp1)/
Slc11a1 transporter was used in the study], or oxygen (albeit
the oxygen pressure in the culture medium was likely not the
one found in the tissues of the animal). Potassium levels were
likely high, and data suggested that gluconate was the carbon
and energy source available to vacuolar salmonellae. The dif-
ferences between this study and the STM analysis may high-
light inherent limitations in using a particular method (e.g., low
sensitivity regarding the levels of gene expression taking place,
existence of redundant or alternative pathways, competition or
complementation in the heterogeneous populations analyzed in
the STM assays).
Schnappinger et al. [79] looked at the gene expression of M.
tuberculosis and found 601 genes differentially regulated in
intraphagosomal microorganisms, accounting for approxi-
mately 15% of the mycobacterial genome. It is interesting that
a selected number of the genes, whose expression was up-
regulated by the phagosomal environment, were also induced
in vivo in the mycobacteria that infected the mouse lung. The
genes that were induced upon phagosomal residence included
those involved in fatty acid catabolism, the glyoxylate cycle,
and mycobactin synthesis, suggesting that the mycobacterial
phagosome is poor in iron and that mycobacteria rely on lipids
for a source of carbon and energy. When they compared the
phagosome-induced response with other regulons, they found
that many genes were co-regulated in those in vitro conditions
and in the intraphagosomal environment. Specifically as to
what concerns this analysis, 35 genes were induced in IFN--
activated macrophages or in broth culture by exposure to low
iron concentrations. It is interesting that the magnitude of
induction of these genes was higher in macrophages that were
able to produce NO than in inducible NO synthase (iNOS)/
cells, suggesting that the response could be partly related to
NO damage and not to iron deprivation or alternatively, that
NO exacerbates iron deprivation. Many hypoxia-induced genes
were also induced inside the macrophage in M. tuberculosis.
Finally, there was also a series of genes that was up-regulated
by phagosomal residence and nutrient starvation, and these
were clearly independent of the presence of NO in the cell.
Much of this picture can apply to in vivo-growing M. tubercu-
losis. Timm et al. [80] used a quantitative, real-time polymer-
ase chain reaction approach to analyze gene expression in
tubercle bacilli isolated from infected mice or human patients.
Again, up-regulation of genes responsive to iron deprivation,
glucose starvation, hypoxia, and fatty acid metabolism was
found in mycobacteria extracted from mouse-infected lungs.
The picture for samples taken from human patients was not so
clear-cut, and there was less evidence of iron deficiency or use
of the glyoxylate cycle. A different approach using a promoter
trap strategy confirmed the use of fatty acids in vivo as a carbon
source by M. tuberculosis infecting the lungs of mice, as well as
the likely iron-restrictive environment faced by the mycobac-
terium in vivo [81].
Despite the generation of extremely valuable and extensive
information, the regulons defined by microarray techniques for
different stimuli overlap. For example, of the 36 genes induced
by reactive nitrogen intermediates, 27 were also induced by
hypoxia [82]. Thus, Voskuil et al. [83] have defined a “dor-
mancy regulon”, which can be induced by low NO concentra-
tions or by hypoxia and whose expression can be detected in
vivo in M. tuberculosis extracted from the lungs of infected
mice. High-throughput analysis of gene expression in many
model systems will continue to supply extensive amounts of
raw data, which will be useful in addressing the questions
discussed in this paper.
Manipulation of the intracellular habitat
The manipulation of the intracellular trafficking of certain
microbes has shown that the change in the habitat affects the
survival or proliferative capacity of the microbe. Thus, SifA
mutants of Salmonella, forced into the cytoplasm of macro-
phages, fail to proliferate [84]. Curiously, that is not the case if
the SifA mutants infect epithelial cells where the cytoplasm
can support bacterial growth [85]. In contrast, when the sapro-
phyte Bacillus subtilis was made to express listeriolysin O,
targeting it to the cytoplasm of a macrophage cell line, it
became able to proliferate in this cell type [86]. Using a similar
approach, it was shown that B. suis expressing listeriolysin O
failed to proliferate after lysing the membrane vacuole in
human monocytes [87]. Lack of proliferation in the cytoplasm
might be seen as evidence for the presence of some restricting
factor. This might be simply the lack of some nutrient or the
presence of some toxic antimicrobial factor. In the latter case,
it would obviously have to be specific for some but not all
microbes.
Brucella mutants deficient in the virB genes fail to target
their final replication niche in nonphagocytic cells, a compart-
ment with ER characteristics, remaining in an intermediate
organelle between the ER and autophagic vacuole and losing
their ability to replicate [88]. Whether these observations can
be explained by the lack of suitable, nutritive conditions for the
bacteria in the new cellular compartment is yet unclear. How-
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ever, Brucella do not reach autophagic vacuoles in macro-
phages [89].
Promoting the fusion of phagosomes with lysosomes has
different consequences according to the microbe. M. avium
vacuoles made fusogenic with the lysosomes by co-infecting
macrophages with this mycobacterium and Coxiella remain
hospitable to the mycobacteria, despite the acidification and
the acquisition of lysosomal characteristics [90]. This can be
used as an argument to suggest that the subversion tactics of M.
avium were selected, not to prevent exposure to the toxic
lysosomal environment but to keep the microbe in a nutrient-
favorable site. In the case of the co-infection, such nutrient-
favorable conditions are likely maintained. In contrast, a sim-
ilar strategy applied to M. tuberculosis leads to reduced prolif-
erative capacity, suggesting that indeed, the lysosomal
environment is too harsh for this mycobacterial species. In this
regard, it has been shown that M. avium is more resistant to low
pH than M. tuberculosis [91]. However, using a different strat-
egy, Anes et al. [92] showed that promotion of phagosome/
lysosome fusion with specific fatty acids led to reduced prolif-
eration of M. tuberculosis or M. avium. Also, in the case of
Salmonella, the promotion of phagosome-lysosome fusion leads
to an inability to proliferate [93, 94].
MECHANISMS OF NUTRIENT DEPRIVATION
(NUTRIPRIVE MECHANISMS)
The many different styles of intracellular life make it likely to
expect as many different ways of nutrient acquisition by the
microbe inside the host cell. A major dichotomy can be estab-
lished between those microbes that reside within a membrane
vesicle, whatever its nature, and those that inhabit the cyto-
plasm. Evidence reviewed in the previous section already
highlighted the existence of nutrient deprivation, and Table 1
summarized evidence, suggesting among other things that such
deprivation may not be so severe in the case of the cytoplasm.
At first glance, the latter milieu might sound more appealing,
given the presumed, reduced level of toxicity and the bountiful
supply of nutrients. However, not every microbe might feel at
home in such locale of the cell, as exemplified by the SifA
mutants of Salmonella or the listeriolysin-expressing Brucella,
unable to thrive in the cytoplasm of macrophages [86, 87].
Conversely, feeding inside vesicles may sound more difficult
but might not be so. Vesicles harboring parasites may fuse with
other vesicular compartments and thus, acquire nutrients: The
endosomal route may bring iron in the form of holo-transferrin
[95], and it is not unlikely that other nutrients may be trans-
ported through this organelle; fusion with other intracellular
membrane systems has been described, such as with the ER
[25], where access to proteic material might be at hand; fusion
with autophagic vacuoles, albeit an attractive way to access
cytosolic material, has yet to be shown to be a mechanism used
by pathogens to acquire nutrients. One of the markers often
used to determine the lysosomal nature of a microbial vacuole
is the molecule LAMP-2 (also known as LGP96); this is a
membrane protein associated with the transport of proteins for
subsequent lysosomal degradation [96]. Although speculative,
it is likely that microbes replicating inside LAMP-2-positive
vesicles might use those proteins doomed for degradation for
their own nutritional satisfaction. Pathogens can even subvert
the host cell to use their own transporters, such as is the case
of SLC1A5 [76].
Not much is known about the pathways leading to the
putative deprivation of specific nutrients. One can envision
mechanisms relying on degradative or withholding systems
(enzymes that destroy particular nutrients such as amino acids,
transporters that remove specific compounds from defined in-
tracellular compartments, scavengers of specific substances
such as iron chelators), as well as cellular mechanisms regu-
lating the access of certain molecules to different compart-
ments within the cell or even supracellular mechanisms regu-
lating the access of nutrients to particular cells (e.g., within
structures such as granulomas or abcesses). Figure 1 presents
a summary of some of the possible mechanisms able to lead to
nutrient deprivation.
Constitutive (in-built) mechanisms
Once a particle is ingested by a macrophage, it will be envel-
oped in a vacuole destined to fuse with lysosomes. Many
successful macrophage parasites subvert that default pathway,
not only to escape from the harsh lysosomal environment but
presumably also to gain residence in a nutrient-rich milieu. We
can thus speculate that the killing of a nonsuccessful microbe
may rely not only in the toxic environment it will reach but also
in the scarcity of nutrients of the phagolysosome. One likely
transporter devoted to the depletion of iron and possibly other
divalent cations is the molecule encoded by the gene Nramp1
(now classified as Slc11a1). This transporter is present in the
endosomal compartment of macrophages and can be found in
the phagosomal membrane around ingested M. avium and
Leishmania major [97, 98]. Macrophages with mutant forms of
the transporter are more susceptible to mycobacteria such as
M. avium and M. bovis BCG, to salmonellae, and certain
species of Leishmania [97]. The resistance to M. avium of mice
expressing the functional form of NRAMP1 is overcome by
overloading these animals with iron [99], thus suggesting a role
for iron deprivation in the activity of this transporter. Curi-
ously, M. tuberculosis appears to escape control by this system
[100, 101]. It must be stressed, however, that the effects of
NRAMP1 are pleiotropic and may impinge on other antimicro-
bial systems, namely the iNOS [102]. Infection by M. avium or
loading with iron induced an increase in the Nramp1 gene
expression [103, 104], highlighting the importance of this
transporter in the interaction among this pathogen, the macro-
phage, and iron. Thus, macrophages are constitutively
equipped with nutriprive mechanisms.
Induced mechanisms
A major inducer of macrophage antimicrobial functions is the
cytokine IFN-. It is well known that IFN--activated macro-
phages produce oxidative radicals such as those dependent on
the phagocyte NADH phosphate oxidase and the iNOS (type 2).
Nevertheless, many reports suggest that the control of micro-
bial growth is not fully explained by the activity of these
pathways. Indeed, bacteria such as L. pneumophila, M. avium,
A. phagocytophilum, and L. monocytogenes and the protozoa T.
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cruzi resist the toxicity of NO and may even depend on its
production for survival inside mice [3–9, 105, 106]. Thus, it is
clear that additional antimicrobial mechanisms dependent on
IFN- are triggered, and one of the possibilities is a series of
nutriprive mechanisms.
One of the best-studied of such mechanisms is the effect of
IFN- on iron metabolism. The control of L. pneumophila
proliferation in human monocytes induced by IFN- was as-
sociated with its ability to restrict the access to iron [107].
Activated monocytes were shown to have reduced expression of
the receptor for transferrin, a mechanism that can, at least in
part, account for the phenomenon of iron withholding [107,
108]. Levels of expression of the transferrin receptor on mouse
macrophages were also shown to correlate with their ability to
support the growth of L. monocytogenes [109], and mRNA
levels for the transferrin receptor were seen to decrease fol-
lowing activation with IFN- [104]. Similar iron limitation
mechanisms may underlie the anti-Histoplasma capsulatum
activity of IFN--activated mouse macrophages [110]. Treat-
ment with the cytokines IFN- and TNF leads to a decrease in
the access to iron by mycobacteria [31], although acquisition
through other chelates such as lactoferrin might increase fol-
lowing IFN- activation [32]. However, T. gondii, Chlamydia
psittaci, and Leishmania donovani were shown to avoid these
antimicrobial mechanisms [111], and given the lack of iron
requirements of Borrelia burgdorferi [112], it is expected that
they will not play a role against this pathogen. Cytokines also
affect the expression of the putative iron transporter NRAMP1:
It was shown that IFN- activates macrophages to increase its
expression [98, 103, 113], and TNF enhances the expression of
the Nramp1 gene [104], a phenomenon that is consistent with
the ability of these cytokines to restrict access to iron and to
exert antimicrobial activity.
It is curious that in the study of Schnappinger et al. [79], it
was found that the up-regulation of genes in M. tuberculosis,
which is specifically found in IFN--activated macrophages
and not in nonactivated cells, was strictly dependent on the
production of NO by the phagocytic cell. The lack of a specific
RNA signature for a putative nutriprive mechanism is not,
however, an argument against the existence of such a mecha-
nism. The well-documented restriction of iron, present in non-
activated cells but made more intense upon IFN- activation,
is such a case. Conversely, the change in the requirement for
the glyoxylate cycle enzymes, which occurs during the chronic
stages of the infection by mycobacteria and salmonellae [64,
65], suggests that there are metabolic alterations induced by
the immune response such that the availability of carbon
sources changes.
A second well-known pathway triggered by IFN- and lead-
ing to the deprivation of a nutrient is the activation of the
enzyme IDO, which degrades L-tryptophan into N-formyl-
kynurenine and has been shown to play a role in the control of
Toxoplasma [114–116], Leishmania [115], and Chlamydia in-
fections [115–117]. However, the in vivo significance of the
tryptophan-metabolizing pathways is confounded by the mul-
tiple effects that tryptophan catabolism has on microbes and
the immune system: from simple depletion of the amino acid to
the generation of immunomodulators (e.g., picolinic acid,
shown to promote antimycobacterial activity in macrophages
[118]) and from the deprivation of the microbe to the depriva-
tion of the immune cell [119].
Toll-like receptors (TLRs) may convey antimicrobial signals
to the macrophage following ligation of microbial molecules. It
was shown that engagement of TLR2 on macrophages led to
killing of M. tuberculosis [120]. Although macrophages trig-
gered through TLRs can be induced to produce antimicrobial
Fig. 1. Summary of the possible mechanisms leading to
nutrient deprivation in infected macrophages. The vacuole
containing the pathogen (gray circle) may acquire trans-
porters that remove nutrients (e.g., NRAMP1 may remove
iron), enzymes that degrade specific molecules [e.g., in-
doleamine 2,3-dioxygenase (IDO) may metabolize trypto-
phan], or chelators that sequester certain compounds (e.g.,
iron chelators). Signaling initiated by cytokine, pattern
recognition, or other receptors may also affect the matura-
tion of the vacuole, namely by preventing its interaction
with endosomes (a source of nutrients such as transferrin-
bound iron), its interaction with other subcellular compart-
ments with the generation of special replicative vacuoles or
the lysis of the vacuolar membrane.
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molecules such as NO [120], additional antimicrobial mecha-
nisms are being sought. Blander and Medzhitov [121] de-
scribed deficient phagocytosis of microorganisms in macro-
phages defective in TLR2 and -4 or their signal transducer
myeloid differentiation primary-response protein 88 (MyD88).
It is more interesting that such deficient macrophages showed
impaired maturation of phagosomes, and pathogens such as
salmonellae ended up in a vacuolar compartment different from
the one they normally occupy. These data have, however, not
been reproduced in an independent study using alternative
technical approaches [122]. Also, not every microbe may be
susceptible to this pathway, such as in the case of L. monocy-
togenes [123].
Counteracting the subversion pathways of
parasites
Most of the known mechanisms used by the different microbes
to survive inside macrophages have been described in nonac-
tivated phagocytes. It is thus likely that once cytokine-acti-
vated macrophages are studied, it will be found that many of
these microbial strategies are overcome by the host cell. Spe-
cifically, the inhibition of those subversion pathways that lead
to acquisition of nutrients will fall under our definition of
nutriprive mechanisms of the macrophage. It is known that the
inhibition of acidification of mycobacterial phagosomes is re-
verted upon activation of macrophages with IFN- [124, 125].
In addition to stimulating the secretion of toxic radicals, IFN-
acts on macrophages to induce the expression of a 47-kDa
guanosinetriphosphatase, LRG-47, which promotes the matu-
ration of the mycobacterial phagosome [126]. In the absence of
this effector molecule, the mycobacterial phagosome fails to
acidify in response to IFN-, as there is reduced assembly of
the proton v-ATPase on its membrane, while interacting with
the recycling endosomes and thus acquiring transferrin. The
role of LRG-47 extends to other intracellular microbes such as
T. gondii and L. monocytogenes [127].
The activation of macrophages with IFN- prevents the
normal escape of L. pneumophila through the interaction with
the ER, forcing the Legionella-containing phagosome to follow
the default route of fusion with the lysosome [128]. This is
associated with restriction of growth of the bacterium. What
happens to the use of the SLC1A5 transporter is not yet known.
Also, IFN- activation of macrophages has been shown to
prevent the escape of L. monocytogenes into the cytoplasm of
the macrophage [129] and can thus be seen as activating a
nutriprive mechanism toward this bacterium.
M. tuberculosis dwells in endosomal compartments with ac-
cess to transferrin and thus to iron [95]. The effect of activation,
namely by cytokines, on this mechanism has hardly been
studied. M. avium phagosomes interact actively with the en-
dosomal compartment [12–14]. We have shown that activation
of M. avium-infected macrophages with IFN- plus picolinic
acid effectively restricts mycobacterial growth [118] and at the
same time, severely restricts the fusion of endosomes with the
mycobacterial vacuole [130], thus suggesting a way of restrict-
ing access to nutrients via the endosomal pathway. In this
system, macrophages exhibit some of the alterations typical of
apoptosis and raise the possibility that apoptotic macrophages
limit the access of nutrients to the infecting parasites. It is
interesting to note that apoptosis can be induced through the
TLR signaling pathways, which at least in some cases, were
shown to lead to antimicrobial activity [131–134]. An alterna-
tive way to seclude the intracellular pathogen from the access
to nutrients may involve the induction of autophagy, recently
described to be associated with BCG and M. tuberculosis
killing [135]. It is interesting to note in this regard that a
vitamin D analog can induce autophagic cell death through the
phosphatidylinositol-3 kinase subunit, beclin-1 [136]; it has
been known for a long time that vitamin D3 has an antimyco-
bacterial effect, but the pathways involved are yet unknown.
Leishmania mexicana acquires material (presumably nutri-
ents such as the purines they require to grow) from the cytosol
through two different pathways: One uses an organic anion
transporter assembled in many intracellular vacuoles, namely
those that harbor other pathogens such as H. capsulatum or a
listeriolysin-deficient mutant of L. monocytogenes or even
vacuoles containing inert particles such as immunoglobulin
G-covered latex beads; a second pathway relies on the fusion of
vesicles deriving from autophagic events with the parasitopho-
rous vacuole [17]. Like mycobacteria, the parasitophorous vac-
uole interacts with other membrane compartments of the cell,
thus acquiring cargo from these vesicular compartments [16,
18, 20]. These materials can then be ingested by the parasite
[16]. Again, little is known about how the activation of the
macrophages affects these events.
PERSPECTIVES
The study of nutriprive mechanisms is clearly more difficult
than the search for specific toxic and antimicrobial molecules.
These mechanisms are likely to differ from pathogen to patho-
gen according to its survival strategy inside the phagocytic cell.
Nevertheless, there is already some evidence for constitutive
and induced nutriprive mechanisms. Awareness of the possi-
bility for these mechanisms will help the identification of
additional instances, where they will be relevant in the control
of pathogens. Most of the studies about intracellular trafficking
of pathogens have been performed on resting macrophages.
Assuming that some of the remodeling of intracellular traffick-
ing induced by intramacrophagic pathogens aims at allowing
the residence in a nutrient-rich niche of the cell, more work
about the inhibition of such evasion tactics following activation
signals, which will lead to microbial growth control (e.g., after
activation by cytokines), will be needed. Experimental inter-
ference with the normal pathways of membrane trafficking will
also help in providing clues about the mechanisms of nutrient
acquisition by pathogens. Solute transporters may play an
important role by removing essential nutrients, as in the case of
SLC11A1/Nramp1, or by being subverted by the microbes
themselves and providing them with the required nutrients, as
in the case of SLC1A5. More work in this area will certainly aid
in providing a clearer view about the trafficking of nutrients
inside the infected macrophage. Manipulation of the microbes,
inducing new nutritive requirements or alternatively, comple-
menting their deficiencies, may provide new tools to study the
mechanisms of nutrient deprivation. Finally, the accumulation
of data about expression profiling expected to occur at increas-
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ing rates will create huge amounts of information, which may
be available to those studying these issues.
The understanding of the nutritive requirements of microbial
pathogens and the nutriprive mechanisms induced in the mac-
rophage will provide a framework for the identification of new
targets for chemotherapy, namely inhibitors of the biosynthetic
pathways essential for microbial proliferation and survival.
Harth and Horwitz [137] presented proof of the concept that
interfering with nitrogen metabolism leads to the identification
of antimicrobial drugs. Particularly interesting candidates are
the anaplerotic pathways turned on by limiting carbon sources.
The identification of microbial products turned on after induc-
tion of nutrient deprivation and their use as antigenic targets in
new vaccines can also be envisioned. Dietary manipulation of
phagosome maturation and as we postulate, of access to nutri-
ents may provide yet another singular approach as suggested
by Anes and collaborators [92].
In summary, nutriprive mechanisms, acting in infected mac-
rophages, exist and need to be better understood so that we
gain better insight into infectious diseases caused by intracel-
lular parasites and may one day be able to control them more
effectively.
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